Clinical updates from bipolar telehealth

There appears to be some confusion regarding the efficacy of aripiprazole in bipolar mania and depression and for preventing bipolar episodes. Aripiprazole is approved by the Food and Drug Administration as a treatment for acute mania. It is not one of the more robustly efficacious agents for mania, however; haloperidol, risperidone, olanzapine and quetiapine (in that order) top the list in a meta-analysis by Cipriani.



View this post on https://www.psychiatrictimes.com/article/clinical-updates-bipolar-telehealth